Lecture

Coronaviruses: Insights and Implications

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Description

This lecture by the instructor covers a comprehensive overview of coronaviruses, including the SARS-CoV-2 virus responsible for COVID-19. It delves into the origins of coronavirus infections, symptoms, transmission, and the impact on human health. The presentation also discusses the global epidemiology of COVID-19, the typical course of acute viral infections, and the incubation periods of various diseases. Furthermore, it addresses critical questions surrounding COVID-19, such as the real infection rates, contagiousness of asymptomatic individuals, potential cross-immunity, and the seasonal patterns of the epidemic. The medical status quo regarding treatment, antiviral drugs, vaccine development, and the importance of preventive measures are highlighted.

Official source

Ontological neighbourhood

Health sciences

Infectious diseases: Topics in infectious diseases

Related concepts (29)

Vaccine

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness of vaccines has been widely studied and verified.

COVID-19

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the virus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019. The disease quickly spread worldwide, resulting in the COVID-19 pandemic. The symptoms of COVID‐19 are variable but often include fever, cough, headache, fatigue, breathing difficulties, loss of smell, and loss of taste. Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.

SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. The virus previously had the provisional name 2019 novel coronavirus (2019-nCoV), and has also been called human coronavirus 2019 (HCoV-19 or hCoV-19). First identified in the city of Wuhan, Hubei, China, the World Health Organization designated the outbreak a public health emergency of international concern from January 30, 2020, to May 5, 2023.

Viral disease

A viral disease (or viral infection) occurs when an organism's body is invaded by pathogenic viruses, and infectious virus particles (virions) attach to and enter susceptible cells. Basic structural characteristics, such as genome type, virion shape and replication site, generally share the same features among virus species within the same family. Double-stranded DNA families: three are non-enveloped (Adenoviridae, Papillomaviridae and Polyomaviridae) and two are enveloped (Herpesviridae and Poxviridae).

Polio vaccine

Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization (WHO) recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018. The inactivated polio vaccines are very safe.

Related lectures (64)

COVID-19 Outbreak: Epidemiology and Mitigation

Explores the COVID-19 outbreak, its terminology, transmission, severity, and global impact, emphasizing the importance of mitigation strategies and digital epidemiology.

COVID-19 Outbreak: Transmission & Mitigation

By Prof. Marcel Salathé covers COVID-19 outbreak terminology, transmission modes, severity, and mitigation strategies.

Immunology at SARS-CoV-2

Explores the immune response to Covid-19, vaccine development, and severe symptoms, emphasizing the role of ACE2 and innate immunity.

Design of Immunogenic Vaccines

Explores the design of immunogenic vaccines, boosting immune response through various methods, and addressing challenges in vaccine development.

Immunology of SARS-CoV2